Ellevest, Inc. Clovis Oncology, Inc. Transaction History

Ellevest, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$2.7 - $4.76 $974 - $1,718	-361 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$4.06 - $5.8 $1,465 - $2,093	361 New	361 $2,000
Q4 2020 Feb 04, 2021	SELL	$4.13 - $6.41 $1,168 - $1,814	-283 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$4.82 - $7.72 $1,123 - $1,798	233 Added 466.0%	283 $2,000
Q2 2020 Jul 06, 2020	SELL	$5.69 - $9.69 $273 - $465	-48 Reduced 48.98%	50 $0
Q1 2020 Apr 13, 2020	BUY	$3.77 - $11.0 $369 - $1,078	98 New	98 $1,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.